Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.069 AUD | +2.99% | +11.29% | 0.00% |
06-06 | Easing Rate Hike Concerns Shore Up Australian Shares | MT |
06-06 | Neurotech's Extended NTI164 Drug Trial Yields Further Improvements; Shares Surge Nearly 11% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
0.00% | 45.21M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.43% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Says Considerable Improvement in ASD Patients Treated with NTI164; Shares Decline 9%